Make your Participation Matter
Fight Pancreatic Cancer in the
The HOTLANTA Half Marathon
Participate in the Race above or choose ANY Activity or Event
and work to raise donations for the Fight! Your options are Limitless!
Set up your Fundraising page
Customize your page
with a story and photos
Get the word out, share your mission with family and friends
Once you get your first donation we will send your participation packet containing great information, athletic shirt, awareness bracelets, and other fun goodies!
ABOUT THE EVENT
The HOTLANTA Half Marathon continues its tradition of bringing the love of running to the best of Atlanta! The journey of Atlanta landmarks kicks off at Atlanta’s Pemberton Place – World of Coca-Cola, winding runners through the streets and onto the vista views of the city along the Beltline. Just when you think the course couldn’t get any better, you will pass through historic Piedmont Park and pay homage to the Olympians as you run by Centennial Park.
“It was such an awesome experience for our whole family to be given the opportunity to participate in such a great and meaningful Walk!”
“I am so happy that decided to do this. This weekend was so amazing, seeing all those people come together for this cause was just amazing.”
WHY US? BECAUSE EARLY DIAGNOSIS IS KEY
91% of pancreatic cancer patients will die within five years of diagnosis. There is currently no detection test. If patients are diagnosed in time for surgery, their chance of surviving meaningfully increases. A key approach is to foster a marker to help diagnose the disease earlier.
Together with You our Mission is to promote awareness, increase education, and further pancreatic cancer research aimed at early diagnosis.
What we provide for those who have Pancreatic Cancer today: Free access to the world’s top medical resource. Help in optimizing personal treatment strategies to live longer. This is a massive undertaking supported entirely by your tax-free donations.
What we provide for Pancreatic Cancer patients of the future: Currently, no standard marker exists to diagnose the disease in early stages. Our aim is to support the development of a marker for early diagnosis. If the disease is found even a year earlier, outcomes will begin to improve.